Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 1 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 9/7/2012 12:12:32 PM : Outperform Start Price: $4.92 ALXA Score: -6.13

developments indicate it is rational to expect additional price increases now

Featured Broker Partners


Advertisement